RXI-109 Treatment for Proliferative Vitreoretinopathy (PVR) and other Ocular Disorders

被引：0
|
作者：
Libertine, Lyn [1 ]
Lewis, Geoffrey P. [2 ]
Luna, Gabriel [2 ]
Fisher, Steven K. [2 ]
Cardia, James [1 ]
Panderarinathan, Lakshmipathi [1 ]
Bulock, Karen [1 ]
Pavco, Pamela A. [1 ]
Byrne, Michael [1 ]
机构：
[1] RXi Pharmaceut Corp, Pharmacol, Westborough, MA USA
[2] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2014年 / 55卷 / 13期
关键词：
655 proliferative vitreoretinopathy; 533; gene/expression;
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
1120
引用
收藏
页数：3
相关论文
共 16 条
  • [1] Novel Anti-CTGF RNAi Therapy for Treatment of Proliferative Vitreoretinopathy (PVR) and other Ocular Disorders
    Lewis, Geoffrey
    Byrne, Michael
    Fisher, Steven
    Cardia, James
    Pandarinathan, Lakshmipathi
    Bulock, Karen
    Libertine, Lyn
    Pavco, Pamela
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [2] RXI-109 treatment to reduce the formation of hypertrophic dermal scars
    Barefoot, L.
    Survi, M.
    Cardia, J.
    Bulock, K.
    Dispersyn, G.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2018, 138 (05) : S84 - S84
  • [3] RXI-109 treatment to reduce the formation of keloids following keloidectomy
    Pavco, Pamela
    Libertine, Lyn
    Young, V. Leroy
    Woolery-Lloyd, Heather
    Cauwenbergh, Geert
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB273 - AB273
  • [4] Current and Future Pharmacological Treatment for Proliferative Vitreoretinopathy (PVR)
    Pastor Jimeno, Jose Carlos
    OPHTHALMOLOGICA, 2013, 230 : 27 - 28
  • [5] Retinoic acid (RA) intravitreal implants for the treatment of experimental proliferative vitreoretinopathy (PVR) - Pharmacokinetics and ocular toxicity
    Yang, CH
    Gallemore, RP
    Niccolo, M
    Kasahara, N
    Ashton, P
    Jaffe, GJ
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (04) : 1018 - 1018
  • [6] Thiotepa: Possible use in the treatment and prevention of proliferative vitreoretinopathy (PVR)
    Kon, CH
    Occleston, NL
    Foss, AJ
    Sheridan, C
    Khaw, PT
    Aylward, GW
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1996, 37 (03) : 1805 - 1805
  • [7] Proliferative vitreoretinopathy (PVR) surgery: Scar Wars Five steps to successful treatment of PVR detachment
    Priglinger, S. G.
    Siedlecki, J.
    Hattenbach, L. -O.
    Grisanti, S.
    OPHTHALMOLOGE, 2021, 118 (01): : 18 - 23
  • [8] Antiproliferative effect of mitomycin C in the treatment of experimental proliferative vitreoretinopathy (PVR)
    Chen, SN
    Chao, AN
    Ho, CL
    Lin, SM
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1999, 40 (04) : S947 - S947
  • [9] Update on phase 2 clinical trial results of RXI-109 treatment to reduce the formation of hypertrophic dermal scars
    Libertine, Lyn
    Pavco, Pamela
    Young, V. Leroy
    Paz, Nelly Georgina
    Hunstad, Joseph
    Cauwenbergh, Geert
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB273 - AB273
  • [10] PROLIFERATIVE VITREORETINOPATHY (PVR) - A PERSONAL ACCOUNT OF ITS PATHOGENESIS AND TREATMENT - PROCTOR LECTURE
    MACHEMER, R
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1988, 29 (12) : 1771 - 1783
12